...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: ZHCLF

Narmac, still crickets from your question to IR or info@Zenith, last week?  I am going to go on a limb and say after 11 years of Zen3694 Trials and the fact that at the AGM  in October DM stated the option of going down a cheaper route of a Royalty deal with a BP that a deal will come  between now and  December of 2024.  RVX is dead in the water without a  Zenith deal and yet the  RVX bills keep getting paid so I think a deal is pending ,  I have been wrong with expectations from Zenith  many many times on   but even the sun shines on a dogs ass once in a while  ......

Share
New Message
Please login to post a reply